Krahasoni metodat

	Testi i Permeabilitetit të Qelizave Caco-2	Modelim i Farmakodinamikës Popullative
Fusha	Farmakologji	Farmakologji
Familja	Process / pipeline	Process / pipeline
Viti i origjinës	1989	1992
Krijuesi	Ingrid Hidalgo	Lewis Sheiner and Stephen Roush
Lloji	absorption screening	dose-response modeling
Burimi themelues	Hidalgo, I. J., Raub, T. J., & Borchardt, R. T. (1989). Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology, 96(3), 736-749.	Dahlström, B., & Nyberg, L. (1993). Population pharmacokinetics and pharmacodynamics. Clinical Pharmacokinetics, 24(1), 45-57.
Emërtime të tjera	Caco-2 assay, intestinal permeability, ADME screening	PopPD, population PD, hierarchical PD modeling
Të lidhura	3	3
Përmbledhja	The Caco-2 assay is an in vitro model system using human colon carcinoma cell monolayers to screen drug intestinal permeability. Developed by Hidalgo and colleagues in 1989, Caco-2 cells differentiate into an epithelial barrier resembling intestinal mucosa, enabling rapid assessment of drug absorption potential and identification of transporter-mediated transport.	Population pharmacodynamic (PopPD) modeling integrates pharmacokinetics with individual dose-response relationships across patient populations to characterize drug efficacy and tolerability. Pioneered by Lewis Sheiner and colleagues, PopPD accounts for inter-individual variability in drug effects and enables rational dose optimization and response prediction.